LON:SN - Smith & Nephew Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 1,801
  • Forecasted Upside: 36.34 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,321
▼ -14 (-1.05%)

This chart shows the closing price for SN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Smith & Nephew Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SN

Analyst Price Target is GBX 1,801
▲ +36.34% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Smith & Nephew in the last 3 months. The average price target is GBX 1,801, with a high forecast of GBX 2,020 and a low forecast of GBX 1,579. The average price target represents a 36.34% upside from the last price of GBX 1,321.

This chart shows the closing price for SN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Smith & Nephew. This rating has held steady since January 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
3/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
6/22/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/20/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
12/19/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/10/2021BarclaysLower Price TargetOverweightGBX 1,825 ➝ GBX 1,800
8/2/2021JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,542 ➝ GBX 1,579
7/29/2021Shore CapitalReiterated RatingHold
7/16/2021Berenberg BankReiterated RatingBuyGBX 2,020
7/1/2021BarclaysBoost Price TargetOverweightGBX 1,800 ➝ GBX 1,825
6/9/2021Credit Suisse GroupUpgradeOutperformGBX 1,560 ➝ GBX 1,805
5/18/2021Shore CapitalReiterated RatingHold
4/29/2021Shore CapitalReiterated RatingHold
4/20/2021Berenberg BankReiterated RatingBuyGBX 1,985
3/2/2021Shore CapitalReiterated RatingHold
2/23/2021JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,563 ➝ GBX 1,423
2/12/2021Berenberg BankReiterated RatingBuyGBX 2,005
1/21/2021BarclaysLower Price TargetOverweightGBX 1,900 ➝ GBX 1,875
1/12/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,438
11/2/2020Berenberg BankLower Price TargetBuyGBX 2,090 ➝ GBX 1,975
10/27/2020Shore CapitalReiterated RatingSell
7/30/2020Morgan StanleyLower Price TargetOverweightGBX 1,950 ➝ GBX 1,940
7/30/2020Berenberg BankLower Price TargetBuyGBX 2,150 ➝ GBX 2,090
7/30/2020Credit Suisse GroupLower Price TargetNeutralGBX 1,685 ➝ GBX 1,675
7/30/2020JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,633 ➝ GBX 1,553
7/29/2020Shore CapitalReiterated RatingSell
7/22/2020Credit Suisse GroupReiterated RatingNeutral
7/20/2020JPMorgan Chase & Co.Reiterated RatingNeutral
7/10/2020Berenberg BankLower Price TargetBuyGBX 2,165 ➝ GBX 2,150
7/9/2020Morgan StanleyLower Price TargetBuyGBX 2,165 ➝ GBX 2,150
7/1/2020Shore CapitalReiterated RatingSell
6/23/2020UBS GroupReiterated RatingNeutral
6/18/2020CitigroupLower Price TargetNeutralGBX 1,700 ➝ GBX 1,670
6/4/2020Morgan StanleyUpgradeOverweightGBX 1,990 ➝ GBX 1,950
5/15/2020Credit Suisse GroupLower Price TargetNeutralGBX 1,825 ➝ GBX 1,685
5/7/2020Berenberg BankBoost Price TargetBuyGBX 2,135 ➝ GBX 2,165
5/7/2020JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,658 ➝ GBX 1,633
5/6/2020Shore CapitalReiterated RatingSell
4/28/2020Jefferies Financial GroupLower Price TargetBuyGBX 2,160 ➝ GBX 1,800
4/17/2020Berenberg BankReiterated RatingBuy
4/14/2020CitigroupDowngradeNeutralGBX 2,250 ➝ GBX 1,700
3/31/2020UBS GroupReiterated RatingNeutral
3/31/2020JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,926 ➝ GBX 1,658
3/30/2020Sanford C. BernsteinDowngradeMarket Perform
3/30/2020Shore CapitalReiterated RatingSell
3/26/2020Berenberg BankLower Price TargetBuyGBX 2,335 ➝ GBX 2,135
2/26/2020UBS GroupBoost Price TargetNeutralGBX 1,800 ➝ GBX 1,860
2/25/2020Berenberg BankBoost Price TargetBuyGBX 2,325 ➝ GBX 2,335
2/21/2020JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,711 ➝ GBX 1,926
2/20/2020Shore CapitalReiterated RatingSell
2/17/2020UBS GroupReiterated RatingNeutral
2/12/2020Berenberg BankBoost Price TargetBuyGBX 2,185 ➝ GBX 2,325
2/5/2020JPMorgan Chase & Co.Reiterated RatingNeutral
1/24/2020Shore CapitalReiterated RatingSell
1/21/2020Jefferies Financial GroupLower Price TargetBuyGBX 2,200 ➝ GBX 2,160
1/15/2020The Goldman Sachs GroupLower Price TargetNeutralGBX 1,695 ➝ GBX 1,670
12/5/2019Berenberg BankReiterated RatingBuy
11/21/2019CitigroupInitiated CoverageBuy
11/13/2019The Goldman Sachs GroupBoost Price TargetNeutralGBX 1,685 ➝ GBX 1,695
11/8/2019Shore CapitalReiterated RatingSell
11/4/2019JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,814 ➝ GBX 1,711
11/4/2019Credit Suisse GroupLower Price TargetNeutralGBX 1,770 ➝ GBX 1,725
11/1/2019Berenberg BankLower Price TargetBuyGBX 2,185
10/31/2019Shore CapitalReiterated RatingSell
10/28/2019UBS GroupReiterated RatingNeutralGBX 1,830 ➝ GBX 1,800
10/21/2019Berenberg BankReiterated RatingBuyGBX 2,250
10/21/2019Shore CapitalReiterated RatingSell
10/4/2019Berenberg BankLower Price TargetBuyGBX 2,250
8/6/2019UBS GroupBoost Price TargetNeutralGBX 1,730 ➝ GBX 1,830
7/31/2019Shore CapitalReiterated RatingSell
7/29/2019UBS GroupReiterated RatingNeutral
7/22/2019UBS GroupBoost Price TargetNeutralGBX 1,455 ➝ GBX 1,730
7/12/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
6/10/2019Shore CapitalDowngradeSell
5/9/2019JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,689 ➝ GBX 1,758
5/2/2019UBS GroupReiterated RatingNeutralGBX 1,455
4/26/2019Berenberg BankReiterated RatingHoldGBX 1,475
4/25/2019Credit Suisse GroupReiterated RatingNeutral
3/14/2019UBS GroupReiterated RatingNeutral
2/11/2019JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,477 ➝ GBX 1,516
2/11/2019The Goldman Sachs GroupBoost Price TargetNeutralGBX 1,400 ➝ GBX 1,440
2/8/2019BNP ParibasDowngradeNeutralGBX 1,475 ➝ GBX 1,525
2/8/2019Credit Suisse GroupBoost Price TargetNeutralGBX 1,330 ➝ GBX 1,390
2/8/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
1/28/2019UBS GroupBoost Price TargetNeutralGBX 1,340 ➝ GBX 1,390
1/8/2019JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,477
1/2/2019JPMorgan Chase & Co.DowngradeNeutralGBX 1,477
12/10/2018Morgan StanleyUpgradeOverweightGBX 1,457 ➝ GBX 1,692
12/10/2018Deutsche Bank AktiengesellschaftUpgradeHoldGBX 1,200 ➝ GBX 1,350
11/2/2018Berenberg BankBoost Price TargetHoldGBX 1,370 ➝ GBX 1,475
10/26/2018UBS GroupReiterated RatingNeutral
10/16/2018HSBCDowngradeHoldGBX 1,400 ➝ GBX 1,500
10/5/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
8/8/2018UBS GroupDowngradeNeutralGBX 1,470 ➝ GBX 1,340
7/30/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
7/26/2018Numis SecuritiesBoost Price TargetAddGBX 1,350 ➝ GBX 1,480
7/20/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
7/3/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
5/14/2018Berenberg BankReiterated RatingHoldGBX 1,370
5/8/2018UBS GroupLower Price TargetBuyGBX 1,550 ➝ GBX 1,470
5/4/2018Deutsche Bank AktiengesellschaftDowngradeSell
5/3/2018Jefferies Financial GroupReiterated RatingBuyGBX 1,515
4/25/2018JPMorgan Chase & Co.Reiterated RatingOverweight
4/24/2018Credit Suisse GroupReiterated RatingNeutralGBX 1,290
4/17/2018Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,315 ➝ GBX 1,309.50
4/12/2018Jefferies Financial GroupReiterated RatingBuy
4/5/2018JPMorgan Chase & Co.Boost Price TargetOverweightGBX 1,411 ➝ GBX 1,463
3/26/2018HSBCUpgradeBuyGBX 1,320 ➝ GBX 1,530
2/13/2018Morgan StanleyLower Price TargetEqual weightGBX 1,558 ➝ GBX 1,457
2/9/2018Credit Suisse GroupBoost Price TargetNeutralGBX 1,285 ➝ GBX 1,290
2/7/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,411
2/1/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,411
1/25/2018JPMorgan Chase & Co.UpgradeOverweightGBX 1,369 ➝ GBX 1,411
11/13/2017JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,382 ➝ GBX 1,369
11/6/2017Jefferies Financial GroupReiterated RatingBuyGBX 1,515
11/6/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,382
11/3/2017Berenberg BankReiterated RatingHoldGBX 1,340 ➝ GBX 1,340
10/23/2017Deutsche Bank AktiengesellschaftBoost Price TargetHoldGBX 1,200 ➝ GBX 1,315
10/19/2017JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,361 ➝ GBX 1,382
10/13/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/12/2017Jefferies Financial GroupReiterated RatingBuyGBX 1,515
10/12/2017CitigroupReiterated RatingSellGBX 1,160
10/10/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,361
10/6/2017CitigroupReiterated RatingSellGBX 1,160
9/11/2017The Goldman Sachs GroupReiterated RatingNeutralGBX 1,380
7/31/2017JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,280 ➝ GBX 1,361
7/28/2017Credit Suisse GroupReiterated RatingNeutralGBX 1,280
7/28/2017Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,200
7/28/2017Jefferies Financial GroupBoost Price TargetBuyGBX 1,350 ➝ GBX 1,515
7/25/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,280
7/20/2017Credit Suisse GroupReiterated RatingNeutralGBX 1,200
7/18/2017Berenberg BankReiterated RatingHoldGBX 1,300
7/17/2017Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,200
7/10/2017CitigroupReiterated RatingSellGBX 1,160
6/30/2017The Goldman Sachs GroupReiterated RatingNeutralGBX 1,380
6/22/2017CitigroupReiterated RatingSellGBX 1,160
5/15/2017Morgan StanleyReiterated RatingOverweight
5/15/2017JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,345 ➝ GBX 1,280
5/15/2017Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,200
5/15/2017Credit Suisse GroupBoost Price TargetNeutralGBX 1,160 ➝ GBX 1,200
5/8/2017Morgan StanleyReiterated RatingOverweight
5/8/2017Credit Suisse GroupBoost Price TargetNeutralGBX 1,160 ➝ GBX 1,200
5/8/2017Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,200
5/8/2017JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,345 ➝ GBX 1,280
5/5/2017Numis SecuritiesReiterated RatingAddGBX 1,350
5/5/2017The Goldman Sachs GroupReiterated RatingNeutralGBX 1,270
5/5/2017Jefferies Financial GroupReiterated RatingBuyGBX 1,350
5/5/2017Shore CapitalReiterated RatingHoldGBX 1,144
4/25/2017Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,200
4/4/2017Numis SecuritiesReiterated RatingAddGBX 1,350
3/30/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,345
3/29/2017Jefferies Financial GroupReiterated RatingBuyGBX 1,350
3/21/2017Morgan StanleyReiterated RatingOverweight
3/1/2017JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,260 ➝ GBX 1,345
2/15/2017Berenberg BankLower Price TargetHoldGBX 1,340 ➝ GBX 1,275
2/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetHoldGBX 1,150 ➝ GBX 1,200
2/12/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,260
2/10/2017Morgan StanleyReiterated RatingOverweightGBX 1,301
2/10/2017Jefferies Financial GroupLower Price TargetBuyGBX 1,370 ➝ GBX 1,350
2/9/2017Numis SecuritiesReiterated RatingAddGBX 1,350
2/8/2017Credit Suisse GroupReiterated RatingNeutralGBX 1,190
2/6/2017Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,150
2/6/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,260
1/18/2017Berenberg BankReiterated RatingHoldGBX 1,340
1/12/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,260
1/11/2017Morgan StanleyReiterated RatingOverweight
1/4/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,260
12/7/2016Jefferies Financial GroupLower Price TargetBuyGBX 1,395 ➝ GBX 1,370
12/2/2016Morgan StanleyReiterated RatingEqual weightGBX 1,249
12/2/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,260
11/25/2016The Goldman Sachs GroupLower Price TargetBuyGBX 1,370 ➝ GBX 1,310
11/22/2016UBS GroupReiterated RatingNeutralGBX 1,160
11/7/2016Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 1,150
11/4/2016Jefferies Financial GroupLower Price TargetBuyGBX 1,420 ➝ GBX 1,395
11/4/2016Numis SecuritiesReiterated RatingAddGBX 1,350
11/1/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,199
11/1/2016Jefferies Financial GroupReiterated RatingBuyGBX 1,420
10/31/2016Credit Suisse GroupReiterated RatingNeutralGBX 1,285
10/26/2016Deutsche Bank AktiengesellschaftReiterated RatingHold
10/6/2016Berenberg BankDowngradeHoldGBX 1,485 ➝ GBX 1,340
(Data available from 9/16/2016 forward)

News Sentiment Rating

0.40 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/18/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/20/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/19/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/19/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/18/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/18/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/17/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/16/2021

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Smith & Nephew logo
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Read More

Today's Range

Now: GBX 1,321
Low: 1,294
High: 1,338

50 Day Range

MA: GBX 1,439.66
Low: 1,335
High: 1,570.50

52 Week Range

Now: GBX 1,321
Low: 1,317
High: 1,681.50

Volume

2,658,420 shs

Average Volume

343,671 shs

Market Capitalization

£11.61 billion

P/E Ratio

29.03

Dividend Yield

2.01%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Smith & Nephew?

The following sell-side analysts have issued reports on Smith & Nephew in the last year: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, JPMorgan Chase & Co., and Shore Capital.
View the latest analyst ratings for SN.

What is the current price target for Smith & Nephew?

4 Wall Street analysts have set twelve-month price targets for Smith & Nephew in the last year. Their average twelve-month price target is GBX 1,801, suggesting a possible upside of 36.3%. Berenberg Bank has the highest price target set, predicting SN will reach GBX 2,020 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of GBX 1,579 for Smith & Nephew in the next year.
View the latest price targets for SN.

What is the current consensus analyst rating for Smith & Nephew?

Smith & Nephew currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SN will outperform the market and that investors should add to their positions of Smith & Nephew.
View the latest ratings for SN.

What other companies compete with Smith & Nephew?

How do I contact Smith & Nephew's investor relations team?

Smith & Nephew's physical mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company's listed phone number is +44-20-74017646. The official website for Smith & Nephew is www.smith-nephew.com.